As of 2025-05-15, the Relative Valuation of Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) is 1,327.78 INR. This relative valuation is based on P/E multiples. With the latest stock price at 1,708.20 INR, the upside of Sun Pharmaceutical Industries Ltd based on Relative Valuation is -22.3%.
The range of the Relative Valuation is 1,098.52 - 1,595.45 INR.
| Range | Selected | |
| Trailing P/E multiples | 26.8x - 33.5x | 30.8x |
| Forward P/E multiples | 24.3x - 32.1x | 26.4x |
| Fair Price | 1,098.52 - 1,595.45 | 1,327.78 |
| Upside | -35.7% - -6.6% | -22.3% |
| Date | P/E |
| 2025-05-14 | 35.85 |
| 2025-05-13 | 35.72 |
| 2025-05-12 | 35.46 |
| 2025-05-09 | 36.68 |
| 2025-05-08 | 36.83 |
| 2025-05-07 | 37.37 |
| 2025-05-06 | 38.17 |
| 2025-05-05 | 38.49 |
| 2025-05-02 | 38.30 |
| 2025-04-30 | 38.23 |
| 2025-04-29 | 37.78 |
| 2025-04-28 | 38.66 |
| 2025-04-25 | 37.39 |
| 2025-04-24 | 37.92 |
| 2025-04-23 | 37.46 |
| 2025-04-22 | 36.69 |
| 2025-04-21 | 36.65 |
| 2025-04-17 | 36.87 |
| 2025-04-16 | 35.49 |
| 2025-04-15 | 35.78 |
| 2025-04-11 | 35.42 |
| 2025-04-09 | 34.66 |
| 2025-04-08 | 35.49 |
| 2025-04-07 | 35.19 |
| 2025-04-04 | 35.78 |
| 2025-04-03 | 37.18 |
| 2025-04-02 | 35.97 |
| 2025-04-01 | 35.64 |
| 2025-03-28 | 36.39 |
| 2025-03-27 | 36.39 |
| 2025-03-26 | 36.72 |
| 2025-03-25 | 36.95 |
| 2025-03-24 | 37.44 |
| 2025-03-21 | 37.56 |
| 2025-03-20 | 36.81 |
| 2025-03-19 | 36.36 |
| 2025-03-18 | 36.70 |
| 2025-03-17 | 35.76 |
| 2025-03-13 | 35.25 |
| 2025-03-12 | 35.15 |
| 2025-03-11 | 34.77 |
| 2025-03-10 | 33.79 |
| 2025-03-07 | 33.72 |
| 2025-03-06 | 33.89 |
| 2025-03-05 | 33.06 |
| 2025-03-04 | 32.84 |
| 2025-03-03 | 33.24 |
| 2025-02-28 | 33.37 |
| 2025-02-27 | 34.46 |
| 2025-02-25 | 33.82 |